You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-EED antibody (ab4469)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab4469? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab4469 has been referenced in 6 publications.

  1. Yap DB et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117:2451-9 (2011). WB; Human. PubMed: 21190999
  2. Borbone E et al. Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab 96:1029-38 (2011). PubMed: 21289264
  3. Choudhury SR et al. (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis 32:1525-32 (2011). PubMed: 21798853
  4. Philipp S et al. The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase. Proc Natl Acad Sci U S A 107:1112-7 (2010). WB, ICC/IF; Human. PubMed: 20080539
  5. Maenner S et al. 2-D structure of the A region of Xist RNA and its implication for PRC2 association. PLoS Biol 8:e1000276 (2010). WB. PubMed: 20052282
  6. Ross PJ et al. Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development. Reproduction 136:777-85 (2008). WB, IHC-FoFr; Cow. PubMed: 18784248

Publishing research using ab4469? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"